drugset / Trial / NCT01678534

Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial

NCT01678534 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase IIa clinical trial, pilot, single centre, prospective, randomized, double-blind, placebo-controlled, with sequential inclusion of patients

Timeline

Start
2014-09
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogenic mesenchymal stem cells from adipose tissue Cell therapy 1e+06 unknown Intravenous

Indications